Jiwu Wei

8PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 14, 2025
A bispecific antibody targeting PD-L1/TNFR2 increases tumor targeting and enhances antitumor efficacy in colorectal cancer.

Xiaozhen Kang, Peng Qian, Yifeng Han

|Apr 01, 2025
Targeted release of a bispecific fusion protein SIRPĪ±/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors.

Yenan Zhang, Bohao He, Peng Zou

|Mar 08, 2024
An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy.

Shibing Wang, Yuxin Li, Chuning Xu

|Jul 20, 2023
Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma.

Shiqun Wang, Wei Yan, Lingkai Kong

|May 28, 2022
Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy.

Shiqun Wang, Jiwu Wei

|Sep 07, 2021
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8+ T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma.

Hailin Zhang, Yonghui Zhang, Jie Dong

Pageof 2

Frequent Collaborators

1 joint publications

Aiqin Jiang

1 joint publications

Shiqun Wang

1 joint publications

Jie Dong

1 joint publications

Xiaozhen Kang